Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 29, 2014
The minus-end actin capping protein, UNC-94/tropomodulin, regulates development of the Caenorhabditis elegans intestineElisabeth Cox-Paulson, Vincent Cannataro, Thomas Gallagher, et al.The Journal of Clinical Investigation|November 16, 2013
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expressionChristian Mueller, Jeffrey D Chulay, Bruce C Trapnell, et al.Journal of Neurology|March 8, 2017
Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALSNeil G Simon, Jim Lagopoulos, Sita Paling, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2019
A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna MagnaToloo Taghian, Miklos G Marosfoi, Ajit S Puri, et al.Blood Advances|August 8, 2020
Adenosine monophosphate deaminase 3 null mutation causes reduction of naive T cells in mouse peripheral bloodXiaoming Zhan, Xue Zhong, Jin Huk Choi, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Essential requirement for nicastrin in marginal zone and B-1 B cell developmentJin Huk Choi, Jonghee Han, Panayotis C Theodoropoulos, et al.International Journal of Developmental Disabilities|May 28, 2026
Are you coping how I'm coping? An exploratory factor analysis of the Brief-COPE among caregivers of children with and without learning disabilities during COVID-19 restrictions in the UKFreyja Steindorsdottir, Karen Goodall, Hope Christie, et al.JCPP Advances|September 22, 2025
A longitudinal study of psychological distress during and after COVID-19 restrictions in caregivers of children with intellectual disability in the UKKarri Gillespie-Smith, Karen Goodall, Doug McConachie, et al.Nature Medicine|February 11, 2022
AAV gene therapy for Tay-Sachs diseaseTerence R Flotte, Oguz Cataltepe, Ajit Puri, et al.The New England Journal of Medicine|February 10, 2026
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 TrialConnor J Lewis, Precilla D'Souza, Jean M Johnston, et al.Pageof 21